- Home
- ANF vs TERN Comparison
ANF vs TERN Comparison
Compare ANF & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANF | TERN |
|---|---|---|
| Founded | 1892 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.8B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ANF | TERN |
|---|---|---|
| Price | $96.99 | $52.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $120.83 | $46.49 |
| AVG Volume (30 Days) | 956.8K | ★ 11.2M |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ 10.46 | N/A |
| Revenue | ★ $5,266,292,000.00 | N/A |
| Revenue This Year | $5.10 | N/A |
| Revenue Next Year | $3.83 | N/A |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | ★ 6.42 | N/A |
| 52 Week Low | $65.45 | $2.67 |
| 52 Week High | $133.11 | $53.19 |
Technical Indicators
Market Signals| Indicator | ANF | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 56.00 | 73.39 |
| Support Level | $91.25 | $52.42 |
| Resistance Level | $103.44 | $53.19 |
| Average True Range (ATR) | 4.32 | 0.13 |
| MACD | 0.08 | -0.43 |
| Stochastic Oscillator | 51.68 | 62.77 |
Price Performance
Historical ComparisonAbout ANF Abercrombie & Fitch Company
Abercrombie & Fitch Co is a digitally led, omnichannel retailer offering apparel, personal care products, and accessories for men, women, and kids through company-owned stores, digital channels, and third-party arrangements. The company operates through three geographic segments: Americas, the maximum revenue generator; Europe, the Middle East and Africa (EMEA); and Asia-Pacific (APAC). Its brand families include Abercrombie brands and Hollister brands. The Americas segment covers North and South America, EMEA includes Europe, the Middle East and Africa, and APAC includes the Asia-Pacific region, including Asia and Oceania.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.